Proteasome inhibitor therapy for antibody-mediated rejection

Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis

(2011) A. M. Gomez et al.   JOURNAL OF IMMUNOLOGY

Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition

(2011) R. Carlin Walsh et al.   TRANSPLANTATION

The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In Vivo

(2011) Tayyab S. Diwan et al.   TRANSPLANTATION

Making Sense of Desensitization

(2010) H. M. Gebel et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange

(2010) Daniel S. Warren et al.   IMMUNOLOGIC RESEARCH

Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

(2010) R Carlin Walsh et al.   TRANSPLANTATION

The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation

(2010) Stuart M. Flechner et al.   TRANSPLANTATION

De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure

(2009) L. G. Hidalgo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

(2009) M. J. Everly et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The Impact of C4d Pattern and Donor-Specific Antibody on Graft Survival in Recipients Requiring Indication Renal Allograft Biopsy

(2009) A. Haririan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Subclinical Rejection in Stable Positive Crossmatch Kidney Transplant Patients: Incidence and Correlations

(2009) E. S. Kraus et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor-Specific Antibodies

(2009) A. Loupy et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Endothelial Gene Expression in Kidney Transplants with Alloantibody Indicates Antibody-Mediated Damage Despite Lack of C4d Staining

(2009) Banu Sis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure

(2009) G. Einecke et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Focal C4d+ in Renal Allografts Is Associated with the Presence of Donor-Specific Antibodies and Decreased Allograft Survival

(2009) R. L. Kedainis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of rituximab therapy for treatment of acute humoral rejection

(2009) Z. Kaposztas et al.   CLINICAL TRANSPLANTATION

Emerging role of donor-specific anti–human leukocyte antigen antibody determination for clinical management after solid organ transplantation

(2009) Adriana Zeevi et al.   HUMAN IMMUNOLOGY

The 26 S Proteasome: From Basic Mechanisms to Drug Targeting

(2009) Ami Navon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development

(2009) Derrick J. Todd et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Proteasome inhibitors in the treatment of multiple myeloma

(2009) J J Shah et al.   LEUKEMIA

First-line bortezomib benefits patients with multiple myeloma

(2009) Meletios A. Dimopoulos et al.   Nature Reviews Clinical Oncology

Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation

(2009) Stanley C. Jordan et al.   TRANSPLANTATION

Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production

(2008) D. K. Perry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Addition of Plasmapheresis Decreases the Incidence of Acute Antibody-Mediated Rejection in Sensitized Patients with Strong Donor-Specific Antibodies

(2008) E. Akalin et al.   Clinical Journal of the American Society of Nephrology

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

(2008) Ashley A. Vo et al.   NEW ENGLAND JOURNAL OF MEDICINE

The critical role of plasmapheresis in ABO-incompatible renal transplantation

(2008) Aaron A.R. Tobian et al.   TRANSFUSION

Transplant Glomerulopathy: Risk and Prognosis Related to Anti-Human Leukocyte Antigen Class II Antibody Levels

(2008) Naim Issa et al.   TRANSPLANTATION

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

(2008) Matthew J. Everly et al.   TRANSPLANTATION